We are live on ! Find out more
AMRI

Albany Molecular Research Inc
AMRI

Delisted

AMRI was delisted on the 31st of August, 2017.

Back to rankings

2 hedge funds and large institutions have $3.44M invested in Albany Molecular Research Inc in 2017 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 133 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 136 → 2 (-134)

99% less capital invested

Capital invested by funds: $677M → $3.44M (-$674M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 133

Holders
2
Holders Change
-134
Holders Change %
-98.53%
% of All Funds
0.05%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
133
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AA
Ancora Advisors
Ohio
+$871K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$80M
2
ACM
American Capital Management
New York
-$55.9M
3
Deutsche Bank
Deutsche Bank
Germany
-$52M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$33.9M
5
Citigroup
Citigroup
New York
-$30.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
AllianceBernstein
26
AllianceBernstein
Tennessee
– -$7.2M -331,999 Closed
D.E. Shaw & Co
27
D.E. Shaw & Co
New York
– -$6.92M -318,662 Closed
PC
28
Paulson & Co
New York
– -$6.82M -314,200 Closed
Renaissance Technologies
29
Renaissance Technologies
New York
– -$6.41M -295,542 Closed
GF
30
Gabelli Funds
New York
– -$6.02M -277,545 Closed
LIM
31
Longfellow Investment Management
Massachusetts
– -$5.97M -275,000 Closed
GLAM
32
Gardner Lewis Asset Management
Pennsylvania
– -$4.88M -224,637 Closed
Goldman Sachs
33
Goldman Sachs
New York
– -$4.75M -218,946 Closed
Geode Capital Management
34
Geode Capital Management
Massachusetts
– -$4.62M -212,835 Closed
KCM
35
Kennedy Capital Management
Missouri
– -$4.42M -203,823 Closed
Wells Fargo
36
Wells Fargo
California
– -$4.33M -199,400 Closed
Fisher Asset Management
37
Fisher Asset Management
Washington
– -$4.01M -184,589 Closed
KAM
38
Kassirer Asset Management
Ontario, Canada
– -$3.94M -181,394 Closed
Principal Financial Group
39
Principal Financial Group
Iowa
– -$3.71M -171,060 Closed
Russell Investments Group
40
Russell Investments Group
United Kingdom
– -$3.55M -163,471 Closed
GI
41
GAMCO Investors
Connecticut
– -$3.52M -162,073 Closed
HCM
42
Highbridge Capital Management
New York
– -$3.25M -150,000 Closed
OAC
43
OMERS Administration Corp
Ontario, Canada
– -$3.12M -143,900 Closed
MOACM
44
Mutual of America Capital Management
New York
– -$2.92M -134,625 Closed
PP
45
PDT Partners
New York
– -$2.9M -133,514 Closed
Two Sigma Investments
46
Two Sigma Investments
New York
– -$2.87M -132,055 Closed
CS
47
Credit Suisse
Switzerland
– -$2.74M -126,229 Closed
Barclays
48
Barclays
United Kingdom
– -$2.67M -122,925 Closed
Loomis, Sayles & Company
49
Loomis, Sayles & Company
Massachusetts
– -$2.62M -120,746 Closed
Ameriprise
50
Ameriprise
Minnesota
– -$2.6M -119,580 Closed
1
2
3 4 5

AMRI Hedge Fund Activity: Q3 2017 in Review

2 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Albany Molecular Research Inc (AMRI) for Q3 2017, worth a combined $3.44M — down 99% from $677M a quarter earlier.

Sellers outnumbered buyers: 133 funds closed out of AMRI and 0 opened new positions — a net loss of 133 holders — while 0 trimmed existing stakes and 1 added.

The largest buyer was Ancora Advisors, adding an estimated $871K. The largest seller was BlackRock, exiting entirely with an estimated $80M sold.

  • 2 institutional investors held Albany Molecular Research Inc (AMRI) as of Q3 2017, down from 136 in Q2 2017.
  • Funds reported $3.44M of Albany Molecular Research Inc stock for Q3 2017, down 99% quarter-over-quarter.
  • 0 funds opened new Albany Molecular Research Inc positions in Q3 2017 and 133 closed out, a net change of -133 holders.
  • The largest Albany Molecular Research Inc buyer in Q3 2017 was Ancora Advisors, an estimated $871K added.
  • The largest Albany Molecular Research Inc seller in Q3 2017 was BlackRock, an estimated $80M sold.

Based on aggregated 13F filings for Q3 2017.